Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial

…, L Porteous, E Prince, E Sonuga-Barke, JO Warner… - The lancet, 2007 - thelancet.com
Background We undertook a randomised, double-blinded, placebo-controlled, crossover
trial to test whether intake of artificial food colour and additives (AFCA) affected childhood …

[HTML][HTML] Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study

…, C Jones, MG Semple, JO Warner… - European …, 2022 - Eur Respiratory Soc
Background The long-term sequelae of coronavirus disease 2019 (COVID-19) in children
remain poorly characterised. This study aimed to assess long-term outcomes in children …

Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis

…, JA Warner, SL Johnston, JO Warner - American journal of …, 2003 - atsjournals.org
We examined the in vivo immune response of infants to natural respiratory syncytial virus (RSV)
infection through analysis of cytokine levels in nasal lavage fluid and stimulated …

The effects of a double blind, placebo controlled, artificial food colourings and benzoate preservative challenge on hyperactivity in a general population sample of …

B Bateman, JO Warner, E Hutchinson… - Archives of disease in …, 2004 - adc.bmj.com
Aims: To determine whether artificial food colourings and a preservative in the diet of 3 year
old children in the general population influence hyperactive behaviour. Methods: A sample …

A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study

…, PR Williamson, A Guekht, JO Warner… - The Lancet …, 2022 - thelancet.com
Health consequences that persist beyond the acute infection phase of COVID-19, termed
post-COVID-19 condition (also commonly known as long COVID), vary widely and represent a …

A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 …

JO Warner - Journal of Allergy and Clinical Immunology, 2001 - Elsevier
Background: Because asthma is not a curable condition, the development of strategies for
prevention of the disease has a high priority. Atopic dermatitis is a common precursor to the …

Dietary prevention of allergic diseases in infants and small children: Part III: Critical review of published peer‐reviewed observational and interventional studies and …

…, U Wahn, JA Warner, JO Warner… - Pediatric Allergy and …, 2004 - Wiley Online Library
The role of primary prevention of allergic diseases has been a matter of debate for the last
40 years. In order to shed some light on this issue, a group of experts of the Section of …

… published articles in Pediatric Allergy and Immunology 2004, by an expert group set up by the Section on Pediatrics, European Academy of Allergology and Clinical …

…, U Wahn, JA Warner, JO Warner… - Pediatric allergy and …, 2008 - Wiley Online Library
Because of scientific fraud four trials have been excluded from the original Cochrane meta‐analysis
on formulas containing hydrolyzed protein for prevention of allergy and food …

An evaluation of the sensitivity of subjects with peanut allergy to very low doses of peanut protein: a randomized, double-blind, placebo-controlled food challenge …

…, JA Nordlee, SL Hefle, SL Taylor, JO Warner - … of Allergy and Clinical …, 1997 - Elsevier
Background: The minimum dose of food protein to which subjects with food allergy have
reacted in double-blind, placebo-controlled food challenges is between 50 and 100 mg. …

Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID‐19

…, JT Scott, MG Semple, JO Warner… - Clinical & …, 2021 - Wiley Online Library
Background The long‐term sequalae of COVID‐19 remain poorly characterized. We assessed
persistent symptoms in previously hospitalized patients with COVID‐19 and assessed …